Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. buy Raymond James

Start price
€1.27
08.11.23 / 50%
Target price
€3.75
08.11.24
Performance (%)
170.93%
End price
€3.43
09.11.24
Summary
This prediction ended on 09.11.24 with a price of €3.43. The BUY prediction by Raymond_James for ProQR Therapeutics N.V. saw massive gains of 170.93%. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
ProQR Therapeutics N.V. 13.091% 13.091% -25.324%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Raymond_James for this prediction

In the thread ProQR Therapeutics N.V. diskutieren
Prediction Buy
Perf. (%) 170.93%
Target price 3.748
Change
Ends at 08.11.24

ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Raymond James from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat

In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) 170.93%
Target price 3.748
Change
Ends at 08.11.24

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Raymond_James for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€3.19
29.10.24
€12.97
29.10.25
-30.89%
30.10.25